Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

                CVM Updates

CVM Updates Home
          Animal & Veterinary
          News & Events
          CVM Updates
          FDA Approves First Generic Maropitant Citrate Tablets for Use in Dogs to Prevent VomitingCVM Updates FDA Approves First Generic Maropitant Citrate Tablets for Use in Dogs to Prevent Vomiting
  
  	
    Share
    Post
    Linkedin

    Email
    PrintMarch 31, 2023

Today the U.S. Food and Drug Administration approved Maropitant Citrate tablets for the prevention of acute vomiting and the prevention of vomiting due to motion sickness in dogs.

Maropitant Citrate is an antiemetic drug that contains the same active ingredient (maropitant citrate) in the same concentration and dosage form as the approved brand name drug product, Cerenia tablets, which was first approved on January 29, 2007.  In addition, the FDA determined that Maropitant Citrate tablets contain no inactive ingredients that may significantly affect the bioavailability of the active ingredient.

Maropitant Citrate is only available by prescription from a licensed veterinarian because professional veterinary expertise is needed to determine whether Maropitant Citrate is an appropriate treatment.

The product labeling warns that people handling, administering, or exposed to Maropitant Citrate may have allergic skin reactions if they get the product on their skin. People administering the product should wash their hands with soap and water after administering the drug. Maropitant Citrate may also cause eye irritation if the product gets in the eye. In the case of accidental eye exposure, people should flush their eyes with water for 15 minutes and seek medical attention.

Maropitant Citrate is supplied in 16, 24, 60, or 160 mg of maropitant as maropitant citrate per tablet. Each tablet strength is scored and packaged in blister packs containing four tablets per perforated sheet.

Maropitant Citrate is sponsored by ZyVet Animal Health Inc., based in Pennington, New Jersey.

For more information:

Freedom of Information Summary**Issued by FDA Center for Veterinary Medicine.
For questions, Contact CVM.**

                                                                                  Content current as of:
      03/31/2023CVM Updates
 
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop